Alphabet's health-tech company Verily gets $800 million from Singapore investment firm Temasek

Alphabet’s life science arm, Verily Life Sciences (“Verily”), has announced it has received an $800 million investment from Singapore-based investment firm Temasek. Formerly known as Google Life Sciences, Verily once constituted part of Google X, Alphabet’s stealth R&D division, but rebranded as Verily in 2015 as a completely independent Alphabet company. In a nutshell, Verily […]